Global Alliance for Regenerative Medicine
GARM Clinic is a privately held, founder-led regenerative medicine operator in Roatán, Honduras and Paradise Island, Bahamas that delivers autologous stem cell therapies, gene therapies, exosomes, and longevity protocols to affluent international medical tourists seeking treatments not yet approved by the US FDA.
- Company typePrivate
- Founded2014
- HeadquartersRoatán, Honduras
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Global Alliance for Regenerative Medicine does
Global Alliance for Regenerative Medicine (GARM Clinic) is a privately held, founder-led regenerative medicine operator founded in 2014 by Dr. Glenn C. Terry, a US board-certified orthopedic surgeon formerly of the Hughston Clinic and US Olympic Team physician. GARM delivers autologous and donor-derived stem cell therapies, gene therapies (Follistatin and VEGF plasmids), exosome therapy, PRP, advanced IV drips, and proprietary protocols (DiscShield, Brain RESET, Biological Reset, Klotho via lipid nanoparticle) through two clinical sites: the flagship in Parrot Tree, Roatán, Honduras — operating within the Próspera autonomous special economic zone — and a second facility opened in 2024 on Paradise Island, Bahamas, under the Bahamas' Longevity and Regenerative Therapies Act. Both jurisdictions permit regenerative and gene therapies not yet approved by the US FDA, which is the structural basis of GARM's market position.
The company runs a direct-to-consumer medical-tourism model targeting affluent international patients (primarily from the US, Canada, and Europe) seeking non-surgical orthopedic care, chronic disease interventions (arthritis, autoimmune conditions, COPD, type 2 diabetes), elite-athlete recovery, and longevity optimization. Patients receive individually customized, physician-led protocols priced per treatment on a fee-for-service basis, with concierge support for travel, lodging, and telemedicine follow-up; a subscription-based Longevity Program is also offered. Revenue streams include treatment fees, CRO-style clinical trial hosting (notably Klothea Bio's Phase 1b AKL003 alpha-Klotho mRNA trial), partner-product distribution (Nymox's Nymozarfex), and resort-based IV/aesthetic services delivered through a Kimpton Grand Roatan spa partnership.
GARM markets through high-leverage channels — a Netflix documentary feature, Joe Rogan podcast exposure, Kevin Harrington (original Shark Tank) partnership, Departures Magazine coverage, and XPRIZE Healthspan semifinalist status for the Brain RESET Protocol. The clinic has 1–10 employees, no disclosed outside funding, and is bootstrapped under founder and CEO Heather Terry's executive leadership. Recent strategic activity (2024–2026) — Bahamas launch, Klotho residency program, clinical trial hosting, new drug distribution, and resort partnership — indicates a transition from a single-clinic concierge practice toward a multi-jurisdiction regenerative-medicine platform with CRO and recurring-revenue components.
Global Alliance for Regenerative Medicine firmographics
Firmographics- Name
- Global Alliance for Regenerative Medicine
- Legal name
- Global Alliance for Regenerative Medicine
- Website
- https://garmclinic.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- GARM Clinic is a privately held, founder-led regenerative medicine operator in Roatán, Honduras and Paradise Island, Bahamas that delivers autologous stem cell therapies, gene therapies, exosomes, and longevity protocols to affluent international medical tourists seeking treatments not yet approved by the US FDA.
- Ownership category
- akta.pro rank
Global Alliance for Regenerative Medicine industry classification
Industry- Product category
- Regenerative Medicine
- NAICS
- Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)
- akta.pro primary industry
- Cell Therapy Developers (Autologous) (HLAAABAA)
- akta.pro secondary industries
- Stem Cell Therapies (MSC/iPSC/HSC-derived) (HLAAABAE), Stem Cell–Based Regenerative Therapies (HLAAAGAA), Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring) (HLAAABAJ), Gene Therapy Delivery Devices & Administration Systems (catheters, intrathecal, ocular delivery) (HLAAACAL), Nephrology & Urology Specialty Pharmaceuticals (HLAIACAH)
Keywords
Where Global Alliance for Regenerative Medicine is headquartered
LocationHeadquarters
- HQ city
- Roatán
- HQ country
- Honduras
- HQ region
- Latin America
Offices3 records
Markets served
Global Alliance for Regenerative Medicine business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Regenerative Medicine Treatments: Fee-for-service medical treatments including stem cell therapies, gene therapies, exosome treatments, and PRP. Customized treatment protocols priced individually based on patient needs and treatment complexity.
- Clinical Trial Hosting (CRO): Contract Research Organization model hosting clinical trials for regenerative medicine companies. Manages portfolio of therapies undergoing clinical testing.
- Longevity Programs: Comprehensive multi-modal longevity packages combining diagnostics, gene therapies, stem cell treatments, and ongoing wellness protocols.
- Spa Partnership Treatments: Regenerative therapies and aesthetic treatments offered through Kimpton Grand Roatan's Kao Kamasa Spa partnership including IV therapies, longevity drips, and regenerative aesthetics.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Customized autologous stem cell treatments - individually priced based on patient needs |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels8 records
Global Alliance for Regenerative Medicine product offering
Product offeringCore offering
GARM Clinic operates a regenerative medicine medical tourism platform delivering stem cell therapies (autologous, allogeneic, cultured, and MUSE-derived), gene therapies (Follistatin and VEGF plasmid), exosome therapies, PRP, and longevity protocols to affluent international patients. Treatments are physician-led, customized per patient after comprehensive diagnostics, and delivered at facilities in Roatán, Honduras and Paradise Island, Bahamas under regulatory frameworks that allow therapies not yet FDA-approved in the US.
Product overview
GARM Clinic operates as a multi-service regenerative medicine platform offering a comprehensive portfolio of cellular, gene, and biologic therapies organized around four core pillars: Stem Cell Therapy (autologous, allogeneic, cultured, and MUSE-derived), Gene Therapy (Follistatin and VEGF plasmid), Advanced IV Therapies (longevity, restorative, and performance drips), and Longevity Medicine (Brain RESET Protocol, Biological Reset Protocol, Klotho therapy). The platform also includes specialized programs for Orthopedic/Athlete Care, Regenerative Aesthetics, Wellness Optimization, and specific treatments for HSV, diabetes, COPD, erectile dysfunction, and prostate conditions. The flagship location is on Roatán Island, Honduras, with a newer facility on Paradise Island, Bahamas, both operating under a physician-led, personalized protocol model where treatments are customized per patient after comprehensive diagnostics. GARM serves medical tourists seeking alternatives to conventional medicine and surgery.
Differentiator
Problem solved
Functional benefit
Brands
- GARM Clinic: Primary medical facility brand offering regenerative medicine, stem cell therapies, gene therapies, and longevity programs in Roatán and Bahamas locations.
- GARM × Kimpton Grand Roatán Resort and Spa Partnership
Products and services
- Stem Cell Therapy Stem cell treatments using autologous, allogeneic, cultured, and MUSE-derived stem cells for orthopedic, autoimmune, longevity, and wellness applications. Targeted at patients seeking non-surgical regenerative solutions.
- Follistatin Plasmid Gene Therapy Gene therapy that reverses epigenetic aging by up to 12 years, inhibits myostatin to increase lean muscle mass, preserve muscle, increase bone density, and reduce body fat.
- VEGF Plasmid Gene Therapy Vascular endothelial growth factor gene therapy increasing vascularization and oxygenation to tissues, used for critical limb ischemia and studied for improving endurance and recovery.
- PRP (Platelet-Rich Plasma) Therapy Concentrated platelet injections derived from patient's own blood to accelerate healing and regeneration of tissues.
- Exosome Therapy Biologic-derived signaling molecules that support cellular communication, rejuvenation, and whole-body vitality through placenta-derived exosomes.
- Longevity Program Comprehensive multi-modal program including joint preservation, gene therapies, exosomes, IV stem cells, MUSE cells, and Brain RESET Protocol targeting biological mechanisms of aging.
- Brain RESET Protocol XPRIZE finalist research protocol combining IV exosomes and targeted Low-Intensity Focused Ultrasound (LIFU) to improve memory, reduce cortisol, enhance deep sleep, and alleviate anxiety.
- DiscShield Proprietary non-surgical, image-guided treatment for herniated or leaky discs, degenerative disc disease, and chronic back or neck pain to stabilize and restore spinal disc function.
- Biological Reset Protocol Comprehensive multi-day regimen combining plasmapheresis, targeted IV therapy (NAD+, amino acids, antioxidants), and neurological enhancers for improved sleep, recovery, and cognitive clarity.
- Klotho Longevity Therapy Proprietary intravenous Klotho therapy delivered via lipid nanoparticle platform with pre- and post-procedure serum biomarker monitoring for longevity and anti-aging purposes.
- HSV Immunotherapy Protocol Three-phase immunotherapy protocol for recurrent herpes simplex virus (HSV-1 and HSV-2) that retrains the immune system for sustained viral suppression, demonstrating 50-90% reduction in outbreak frequency.
- Advanced IV Therapies Curated IV therapies including longevity drips (NAD+), restorative drips, performance drips, and regenerative biologic support infusions for energy, recovery, and performance.
- Regenerative Aesthetic Treatments Cellular rejuvenation and precision aesthetics using advanced biologics and growth factors to restore skin health, tone, and texture, including non-surgical facelifts with unfocused acoustic wave technology.
- Erectile Dysfunction Treatment Treatment combining pulsed energy waves with targeted injections of stem cells, optionally optimized with exosome IV.
- Metabolic Optimization and Plasmapheresis Detoxification and oxidative stress reduction protocols using glutathione and essential B vitamins to boost energy, strengthen immunity, and promote cellular health.
- Klotho Longevity Residency Multi-day residency event at Kimpton Grand Roatán Resort featuring Klotho researchers, proprietary intravenous Klotho therapy via lipid nanoparticle platform, and pre/post biomarker monitoring.
- Clinical Trial Hosting (CRO Services) Contract Research Organization model hosting clinical trials for regenerative medicine companies, managing portfolio of therapies undergoing clinical testing in regulatory-favorable jurisdictions.
Quantifiable outcome
- 50-90% reduction in outbreak frequency for HSV patients over 13 years of clinical experience
- +3 more outcomes
Companies that use Global Alliance for Regenerative Medicine
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles5 records
Global Alliance for Regenerative Medicine technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Global Alliance for Regenerative Medicine partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered major, minor and core.
- Nymox Pharmaceutical CorporationmajorFormal agreement to offer Nymozarfex(TM) drug treatment for prostate conditions at GARM facility on Roatan Island. Marks drug's first public availability, with certified urologists providing treatment for medical tourists. Positioned as safer alternative to existing drugs and surgical options with fewer side effects and no anesthesia requirement.
- Klothea BiomajorPhase 1b clinical trial hosting for AKL003, Klothea Bio's alpha Klotho mRNA therapeutic designed to extend human lifespan. Randomized, double-blind, placebo-controlled study enrolling 21 healthy adults (ages 25-75). Trial conducted at GARM Clinic in Próspera, Roatan within autonomous special economic zone regulatory framework.
- Kevin HarringtonmajorStrategic partnership with original Shark Tank investor and entrepreneur Kevin Harrington. Collaboration featured in Harrington's 'American Entrepreneur' venture, marking a significant milestone in regenerative medicine marketing. Aims to provide patients with unparalleled access to cutting-edge information and empower informed health decisions.
- Hospital Cemesa RoatanminorAlliance member partnership with Hospital Cemesa Roatan, opened June 2016. Modern facility with 24-hour emergency services, diagnostic laboratory, 4 operating rooms under JCAHO standards, MRI and angiogram capabilities. Supports expansion of regenerative medicine field with state-of-the-art medical infrastructure.
- Kimpton Grand Roatan Resort & Spa / Kao Kamasa SpacoreCollaboration bringing regenerative IV therapies and aesthetic treatments to resort guests. GARM provides professionally trained medical team inside spa environment while Kimpton curates guest experience. Treatments include IV therapies, longevity drips, restorative drips, performance drips, stem cell & exosome drips, and regenerative aesthetic treatments.
Scale indicators7 records
Recent moves9 records
Expansion highlights6 records
Global Alliance for Regenerative Medicine competitors and assessment
Company assessmentDirect peers
- BioXcellerator: Stem cell therapy clinic in Medellín, Colombia offering autologous and allogeneic treatments for orthopedic, autoimmune, and chronic conditions to international patients. Directly competes with GARM in the medical tourism regenerative medicine space.
- Okyanos Center for Regenerative Medicine: Former Freeport, Bahamas-based regenerative medicine clinic using adult stem cell therapy under Bahamian regulatory framework. Direct geographic and regulatory peer to GARM's Bahamas location.
- Regenexx: US network of interventional orthopedics clinics offering image-guided bone marrow concentrate injections and regenerative therapies. Comparable orthopedic regenerative medicine focus with broader US footprint.
- Infusio: Frankfurt, Germany and US-based regenerative medicine clinic combining stem cell therapy, IV protocols, and longevity treatments. Comparable multi-modal longevity offering to GARM's Biological Reset and Klotho programs.
- StemGenex: California-based stem cell therapy clinic offering autologous adipose-derived stem cell treatments for orthopedic and degenerative conditions. Closest US-domestic comparator with similar cell processing approach.
- AgeRejuvenation: Miami-based regenerative medicine and hormone therapy clinic offering stem cell, PRP, and IV treatments to affluent domestic clientele. Comparable boutique regenerative medicine positioning in the US market.
- Celltex Therapeutics: Autologous mesenchymal stem cell therapy provider operating in Cancun, Mexico, targeting US medical tourists with similar FDA-arbitrage model. Closest structural competitor to GARM in the regenerative medical tourism category.
- Swiss Medica: Regenerative medicine clinic in Switzerland and Serbia offering stem cell therapy and anti-aging protocols to international patients. Comparable premium medical tourism positioning with longevity focus.
Broad incumbents
- NuVasive (Globus Medical): Large medical device company focused on spine and orthopedic surgical solutions. Represents the conventional surgical alternative that GARM positions its regenerative treatments against.
Others
- Klothea Bio: Alpha Klotho mRNA therapeutic developer currently running Phase 1b trial at GARM Clinic. Partner rather than competitor, but illustrative of biotech clients GARM could serve through its CRO platform.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Global Alliance for Regenerative Medicine social profiles
Digital presenceGlobal Alliance for Regenerative Medicine financial estimates
Financial estimateRevenue estimate
Valuation estimate
Global Alliance for Regenerative Medicine leadership team
Management profileNumber of profiles
Profiles9 records
Global Alliance for Regenerative Medicine funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Global Alliance for Regenerative Medicine M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Global Alliance for Regenerative Medicine
What does Global Alliance for Regenerative Medicine do?
GARM Clinic operates a regenerative medicine medical tourism platform delivering stem cell therapies (autologous, allogeneic, cultured, and MUSE-derived), gene therapies (Follistatin and VEGF plasmid), exosome therapies, PRP, and longevity protocols to affluent international patients. Treatments are physician-led, customized per patient after comprehensive diagnostics, and delivered at facilities in Roatán, Honduras and Paradise Island, Bahamas under regulatory frameworks that allow therapies not yet FDA-approved in the US.
Is Global Alliance for Regenerative Medicine a public or private company?
Global Alliance for Regenerative Medicine is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Global Alliance for Regenerative Medicine founded?
Global Alliance for Regenerative Medicine was founded in 2014. It employs 1 to 10 people.
Where is Global Alliance for Regenerative Medicine based?
Global Alliance for Regenerative Medicine is headquartered in Roatán, Honduras, in the Latin America region.
How does Global Alliance for Regenerative Medicine make money?
Four revenue lines are on record. Regenerative Medicine Treatments are the primary driver. The others are clinical Trial Hosting (CRO), longevity Programs and spa Partnership Treatments.
Who are Global Alliance for Regenerative Medicine's main competitors?
Direct peers on record are BioXcellerator, Okyanos Center for Regenerative Medicine, Regenexx, Infusio, StemGenex, AgeRejuvenation, Celltex Therapeutics and Swiss Medica. NuVasive (Globus Medical) is listed as a broad incumbent. Klothea Bio is listed as an others.
Does Global Alliance for Regenerative Medicine have an API?
No public API is recorded for Global Alliance for Regenerative Medicine.
What industry is Global Alliance for Regenerative Medicine in?
Global Alliance for Regenerative Medicine's product category is Regenerative Medicine. Its primary akta.pro industry code is HLAAABAA, Cell Therapy Developers (Autologous), with a secondary code of HLAAABAE, Stem Cell Therapies (MSC/iPSC/HSC-derived). Its NAICS code is 5417 and its SIC code is 8011.